
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor accomplice: T cell exhaustion induced by chronic inflammation
Liguang Fang, Kunjing Liu, Cun Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Liguang Fang, Kunjing Liu, Cun Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Showing 25 citing articles:
Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs
Shengwen Shao, Huilai Miao, Wenxue Ma
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
Shengwen Shao, Huilai Miao, Wenxue Ma
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
T cell senescence: a new perspective on immunotherapy in lung cancer
Mengge Huang, Yuetong Wang, Liguang Fang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Mengge Huang, Yuetong Wang, Liguang Fang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming
Gengyi Zou, Yuanjian Huang, Shengzhe Zhang, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 4
Open Access | Times Cited: 6
Gengyi Zou, Yuanjian Huang, Shengzhe Zhang, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 4
Open Access | Times Cited: 6
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy
Valentine De Castro, Jeanne Galaine, Romain Loyon, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1124-1134
Closed Access | Times Cited: 6
Valentine De Castro, Jeanne Galaine, Romain Loyon, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1124-1134
Closed Access | Times Cited: 6
From MASLD to HCC: What's in the middle?
Alessia Provera, Cristina Vecchio, Anteneh Nigussie Sheferaw, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35338-e35338
Open Access | Times Cited: 5
Alessia Provera, Cristina Vecchio, Anteneh Nigussie Sheferaw, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35338-e35338
Open Access | Times Cited: 5
Cancer and Autoimmune Diseases as Two Sides of Chronic Inflammation and the Method of Therapy
Vladimir Rogovskii
Current Cancer Drug Targets (2024) Vol. 24, Iss. 11, pp. 1089-1103
Closed Access | Times Cited: 4
Vladimir Rogovskii
Current Cancer Drug Targets (2024) Vol. 24, Iss. 11, pp. 1089-1103
Closed Access | Times Cited: 4
Current Research in Drug-Free Cancer Therapies
Akshaya Andavar, Varsha Rajesh Bhagavathi, J Cousin, et al.
Bioengineering (2025) Vol. 12, Iss. 4, pp. 341-341
Open Access
Akshaya Andavar, Varsha Rajesh Bhagavathi, J Cousin, et al.
Bioengineering (2025) Vol. 12, Iss. 4, pp. 341-341
Open Access
Increased expression of the PD-1/PD-L1 regulatory axis in tissue leukocytes from experimental actinomycetoma by Nocardia brasiliensis in BALB/c mice.
Anna Velia Vázquez-Marmolejo, Diana Ivonne Duarte-Mata, Maria Cristina Cruz, et al.
Microbial Pathogenesis (2025), pp. 107697-107697
Closed Access
Anna Velia Vázquez-Marmolejo, Diana Ivonne Duarte-Mata, Maria Cristina Cruz, et al.
Microbial Pathogenesis (2025), pp. 107697-107697
Closed Access
A Self‐Delivery Nanodrug Simultaneously Inhibits COX‐2/PGE2 Mediated Inflammation and Downregulates PD‐L1 to Boost Photoimmunotherapy
Jinmei Lai, Peiling Chen, Qun‐Ying Shi, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 20
Closed Access | Times Cited: 3
Jinmei Lai, Peiling Chen, Qun‐Ying Shi, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 20
Closed Access | Times Cited: 3
New Perspective on the Treatment of Rheumatic Arthritis Based on “Strengthening Body Resistance (Fú Zhèng)” in the Theory of Co-inhibitory Receptor-regulated T-Cell Immunity
Yifei Xu, Linda L. D. Zhong, Qianqian Liang, et al.
Acupuncture and Herbal Medicine (2024) Vol. 4, Iss. 3, pp. 290-294
Open Access | Times Cited: 3
Yifei Xu, Linda L. D. Zhong, Qianqian Liang, et al.
Acupuncture and Herbal Medicine (2024) Vol. 4, Iss. 3, pp. 290-294
Open Access | Times Cited: 3
Tumor-Induced T Cell Polarization by Schwann Cells
Galina V. Shurin, Kavita Vats, Oleg Kruglov, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3541-3541
Open Access | Times Cited: 12
Galina V. Shurin, Kavita Vats, Oleg Kruglov, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3541-3541
Open Access | Times Cited: 12
When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms
Xi-Chen Zhao, Bo Ju, Nuan-Nuan Xiu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Xi-Chen Zhao, Bo Ju, Nuan-Nuan Xiu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Chemotherapy-induced acceleration of DNA methylation-based biological age in breast cancer
Drew Nannini, Rene Cortese, Christopher D VonTungeln, et al.
Epigenetics (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Drew Nannini, Rene Cortese, Christopher D VonTungeln, et al.
Epigenetics (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
A positive-feedback loop suppresses TNBC tumour growth by remodeling tumour immune microenvironment and inducing ferroptosis
Pingting Ye, Chunhui Wang, Yixuan Wen, et al.
Biomaterials (2024) Vol. 315, pp. 122960-122960
Closed Access | Times Cited: 2
Pingting Ye, Chunhui Wang, Yixuan Wen, et al.
Biomaterials (2024) Vol. 315, pp. 122960-122960
Closed Access | Times Cited: 2
From nature to clinic: Quercetin’s role in breast cancer immunomodulation
Liguang Fang, Dandan Gao, Tong Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Liguang Fang, Dandan Gao, Tong Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Cuproptosis-related molecular subtypes direct T cell exhaustion phenotypes and therapeutic strategies for patients with lung adenocarcinoma
Yipan Zhu, Huiting Deng, Xiuyu Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Yipan Zhu, Huiting Deng, Xiuyu Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Sequencing-based transcriptome analysis reveals diversification of immune response- and angiogenesis-related expression patterns of early-stage cervical carcinoma as compared with high-grade CIN
Olga Kurmyshkina, Pavel Dobrynin, П. И. Ковчур, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Olga Kurmyshkina, Pavel Dobrynin, П. И. Ковчур, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Tumor-associated inflammation: the role and research progress in tumor therapy
Jingxia Xu, Xiaoman Xu, Huiwen Zhang, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 102, pp. 106376-106376
Closed Access | Times Cited: 1
Jingxia Xu, Xiaoman Xu, Huiwen Zhang, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 102, pp. 106376-106376
Closed Access | Times Cited: 1
Euphorbia helioscopia L. inhibits lung tumorigenesis through alleviating exhausted T cell induced by chronic inflammation
Wenbin Duan, Ziye Zhou, Yuqing Huang, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119097-119097
Closed Access | Times Cited: 1
Wenbin Duan, Ziye Zhou, Yuqing Huang, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119097-119097
Closed Access | Times Cited: 1
Permafrost viremia and immune tweening
Jaden Penhaskashi, Olivia Sekimoto, Francesco Chiappelli
Bioinformation (2023) Vol. 19, Iss. 6, pp. 685-691
Open Access | Times Cited: 2
Jaden Penhaskashi, Olivia Sekimoto, Francesco Chiappelli
Bioinformation (2023) Vol. 19, Iss. 6, pp. 685-691
Open Access | Times Cited: 2
Opportunities and challenges of low-dose radiation to enable immunotherapy efficacy
Katiuska Passelli, David Repáraz, Fernanda G. Herrera
International review of cell and molecular biology (2023), pp. 137-156
Closed Access | Times Cited: 1
Katiuska Passelli, David Repáraz, Fernanda G. Herrera
International review of cell and molecular biology (2023), pp. 137-156
Closed Access | Times Cited: 1
From Masld to Hcc: What's in the Middle?
Alessia Provera, Cristina Vecchio, Anteneh Nigussie Sheferaw, et al.
(2024)
Closed Access
Alessia Provera, Cristina Vecchio, Anteneh Nigussie Sheferaw, et al.
(2024)
Closed Access
Ionizing Radiation as a Carcinogen
Jeffrey A. Jones, Fathi Karouia, Octav Cristea, et al.
Elsevier eBooks (2024)
Closed Access
Jeffrey A. Jones, Fathi Karouia, Octav Cristea, et al.
Elsevier eBooks (2024)
Closed Access
Efficacy and safety of cemiplimab in cutaneous squamous cell carcinoma on chronic wounds: a French retrospective study
M. Antoszczak, E. Maubec, Ab. Duval-Modeste, et al.
EJC Skin Cancer (2024), pp. 100273-100273
Open Access
M. Antoszczak, E. Maubec, Ab. Duval-Modeste, et al.
EJC Skin Cancer (2024), pp. 100273-100273
Open Access
Integrated multiomics analysis unveils how macrophages drive immune suppression in breast tumors and affect clinical outcomes
Youness Azimzade, Mads H. Haugen, Vessela N. Kristensen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Youness Azimzade, Mads H. Haugen, Vessela N. Kristensen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access